Biography

Rebecca Chambers has served as a member of our board of directors since January 2026. She is currently executive vice president and chief financial officer of Veracyte. Prior to Veracyte, she served as chief financial officer of Outset Medical and held a series of senior finance roles at Illumina, including vice president of financial planning and analysis and vice president of investor relations and treasury. Earlier in her career, she held finance and investor relations roles at Myriad Genetics and Life Technologies. She previously served on the board of Inari Medical until its acquisition by Stryker. Rebecca holds a B.S. in Biology from John Carroll University and an M.B.A. from the S.C. Johnson Graduate School of Management at Cornell University.